AEZS News and Press, Aeterna Zentaris Inc. From 03/15/21

Gainers: Sigma Labs (SGLB) +162%.Check-Cap (CHEK) +110%.Rubius Therapeutics (RUBY) +69%.Luokung Technology (LKCO) +43%.Shaw Communications (SJR) +38%.RumbleON (RMBL) +38%.Aeterna Zentaris (AEZS) +31%.Baosheng Media (BAOS) +30%.Intec Pharma (NTEC) +29%.GenMark Diagnostics (GNMK)...

Analysts Are Bullish On These Penny Stocks Penny stocks can be some of the most fickle investment types to choose. Driven primarily by speculation and “potential,” these cheap shares are well known for their innate ability to fly high. But what are penny stocks rea...

Aeterna Zentaris ([[AEZS]] +17.4%) has exercised its option and has entered into an exclusive worldwide sub-licensable patent and know-how license agreement for a potential COVID-19 vaccine currently in preclinical development that was invented at the Julius-Maximilians-University Wuerzb...

- Company secures next step to continue to build-out pipeline of assets - Company exercised its option to enter into an exclusive license of intellectual property for the development of a proprietary and orally active bacterial vaccine platform technology currently undergoing pre-...

Aeterna Zentaris (AEZS) jumps 9% premarket on expansion of its pipeline by initiating a preclinical development program to develop parathyroid hormone fusion polypeptides ((PTH)) with delayed clearance based on intellectual property exclusively licensed by from The University o...

– Company obtains an exclusive license from The University of Sheffield, UK to intellectual property relating to parathyroid hormone (PTH) fusion polypeptides covering the field of human use which will initially be studied by Aeterna for the potential therapeutic treatment of prima...

Are These Biotech Penny Stocks On Your Watch List Right Now? The tech wreck continues this week, but that hasn’t put a pause on other sectors. Furthermore, the market’s appetite for risk appears to be growing stronger once again. Earlier today, we saw the list of Reddit ...

CHARLESTON, S.C., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that Dr. Klaus Paulini,...

Aeterna Zentaris was one of my previous winners, but a disappointing commercial launch for their flagship product, Macrilen, caused the share price to bleed for most of 2020. The company has been making deals left and right, which brought the share price from around $0.30 to over $3.0...

CHARLESTON, S.C., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced ...